- Home
- SJM vs BMRN Comparison
SJM vs BMRN Comparison
Compare SJM & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SJM
- BMRN
- Stock Information
- Founded
- SJM 1897
- BMRN 1996
- Country
- SJM United States
- BMRN United States
- Employees
- SJM N/A
- BMRN N/A
- Industry
- SJM Packaged Foods
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- SJM Consumer Staples
- BMRN Health Care
- Exchange
- SJM Nasdaq
- BMRN Nasdaq
- Market Cap
- SJM 11.7B
- BMRN 13.7B
- IPO Year
- SJM N/A
- BMRN 1999
- Fundamental
- Price
- SJM $116.44
- BMRN $59.17
- Analyst Decision
- SJM Buy
- BMRN Buy
- Analyst Count
- SJM 9
- BMRN 22
- Target Price
- SJM $125.67
- BMRN $94.00
- AVG Volume (30 Days)
- SJM 1.4M
- BMRN 2.0M
- Earning Date
- SJM 06-05-2025
- BMRN 05-01-2025
- Dividend Yield
- SJM 3.71%
- BMRN N/A
- EPS Growth
- SJM N/A
- BMRN 153.71
- EPS
- SJM N/A
- BMRN 2.21
- Revenue
- SJM $8,788,000,000.00
- BMRN $2,853,915,000.00
- Revenue This Year
- SJM $8.26
- BMRN $12.23
- Revenue Next Year
- SJM $1.90
- BMRN $9.93
- P/E Ratio
- SJM N/A
- BMRN $26.81
- Revenue Growth
- SJM 7.07
- BMRN 17.97
- 52 Week Low
- SJM $98.77
- BMRN $52.93
- 52 Week High
- SJM $125.42
- BMRN $94.85
- Technical
- Relative Strength Index (RSI)
- SJM 55.12
- BMRN 37.64
- Support Level
- SJM $114.30
- BMRN $52.93
- Resistance Level
- SJM $118.79
- BMRN $60.93
- Average True Range (ATR)
- SJM 3.64
- BMRN 3.18
- MACD
- SJM -0.14
- BMRN -0.53
- Stochastic Oscillator
- SJM 65.80
- BMRN 34.01
About SJM The J.M. Smucker Company
J.M. Smucker is a packaged food company that primarily sells through the US retail channel (78% of fiscal 2024 revenue came through its retail pet foods, coffee, and frozen handheld/spreads segments), with the remaining share consisting of Hostess and international (primarily Canada). Retail coffee is its largest category (33% of sales) with brands Folgers and Dunkin'. Pet foods (22% of sales) holds leading brands like Milk-Bone and Meow Mix. Of its remaining, approximately 22% comes from consumer foods, primarily peanut butter and jelly, through brands Jif and Smucker's. The company acquired Hostess Brands in fiscal 2024 to boost its snack and convenience store presence.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.